Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD
Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.
Bariatric surgery more cost-effective than GLP-1s in long term
At current prices, bariatric surgery was more cost-effective than GLP-1 receptor agonists for treatment of obesity, researchers reported at the American College of Surgeons Clinical Congress.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: ACLM celebrating two decades of advancing lifestyle medicine
This year’s American College of Lifestyle Medicine annual conference is taking place in person in Orlando and virtually from Oct. 27 to Oct. 30.
SGLT2 inhibitors may delay kidney complications better than other anti-diabetes agents
SGLT2 inhibitors and GLP-1 were more effective than dipeptidyl peptidase-4 inhibitors and sulfonylurea kidney complications .
Making menopause mainstream: A conversation with Monica Christmas, MD, FACOG, MSCP
Interest in menopause and all things related to midlife women’s health continues to grow, and The Menopause Society is expanding to meet the demand.
Medication hesitancy when addressing patients’ obesity-related atherosclerotic risk
BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.
Medtronic recalls MiniMed insulin pumps due to shorter-than-expected battery life
Medtronic has issued an urgent medical device correction letter warning users of the MiniMed 600 and 700 series of insulin pumps of an increased risk for shorter-than-expected battery life, according to an FDA press release.
Speakers highlight 2024 regulatory moves in hypertension, lipid, diabetes therapies
There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.
Drugs for diabetes, weight loss may also help treat substance use disorders
Ozempic and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid and alcohol use disorders, a new study showed.
Screening, referrals needed for overlooked ‘third pillar’ of PCOS: Psychosocial symptoms
After years of advocacy and research, clinicians increasingly recognize the physical symptoms of polycystic ovary syndrome. Yet, many women with PCOS have a range of serious psychosocial comorbidities that often go unaddressed.
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read